Addition of Everolimus Post VEGFR Inhibition Treatment Failure in Advanced Sarcoma Patients Who Previously Benefited from VEGFR Inhibition: A Case Series

por ElNaggar, Adam C., Hays, John L., Chen, James L.
Publicado 2016

Incidence and contributing factors to termination of the patient-physician relationship

por Santoso, Joseph T., Yibirin, Edmundo, Crigger, Mary, Wan, Jim, ElNaggar, Adam C.
Publicado 2016

Establishment of a Molecular Tumor Board (MTB) and Uptake of Recommendations in a Community Setting

por VanderWalde, Ari, Grothey, Axel, Vaena, Daniel, Vidal, Gregory, ElNaggar, Adam, Bufalino, Gabriella, Schwartzberg, Lee
Publicado 2020

Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer

por Simmons, Daniel, Blank, Stephanie V., ElNaggar, Adam C., Chastek, Benjamin, Bunner, Scott H., McLaurin, Kimmie
Publicado 2022

Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer

por Ulm, Michael A., Redfern, Tiffany M., Wilson, Ben R., Ponnusamy, Suriyan, Asemota, Sarah, Blackburn, Patrick W., Wang, Yinan, ElNaggar, Adam C., Narayanan, Ramesh
Publicado 2020

Impact of COVID-19 on gynecologic oncology patients: an SGO COVID-19 and Gynecologic Cancer Registry study (050)

por Glaser, Gretchen, Lara, Olivia, Pothuri, Bhavana, Grimaldi, Carolina Gomez, Prescott, Lauren, Mastroyannis, Spyridon, Kim, Sarah, ElNaggar, Adam, Torres, Diogo, Conrad, Lesley, McGree, Michaela, Weaver, Amy, Huh, Warner, Cohn, David, Fader, Amanda
Publicado 2022

Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status Phase II LIGHT study primary analysis

por Cadoo, Karen, Simpkins, Fiona, Mathews, Cara, Liu, Ying L., Provencher, Diane, McCormick, Colleen, ElNaggar, Adam C., Altman, Alon D., Gilbert, Lucy, Black, Destin, Kabil, Nashwa, Bennett, James, Munley, Jiefen, Aghajanian, Carol
Publicado 2022

Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up

por Lindskrog, Sia V., Birkenkamp-Demtröder, Karin, Nordentoft, Iver, Laliotis, George, Lamy, Philippe, Christensen, Emil, Renner, Derrick, Andreasen, Tine G., Lange, Naja, Sharma, Shruti, ElNaggar, Adam C., Liu, Minetta C., Sethi, Himanshu, Aleshin, Alexey, Agerbæk, Mads, Jensen, Jørgen B., Dyrskjøt, Lars
Publicado 2023

Clinical outcomes in patients with COVID-19 and gynecologic cancer: A society of gynecologic oncology COVID-19 and gynecologic cancer registry study

por Glaser, Gretchen E., Lara, Olivia D., Pothuri, Bhavana, Grimaldi, Carolina Gomez, Prescott, Lauren S., Mastroyannis, Spyridon A., Kim, Sarah, ElNaggar, Adam C., Torres, Diogo, Conrad, Lesley B., McGree, Michaela, Weaver, Amy, Huh, Warner K., Cohn, David E., Yamada, S. Diane, Fader, Amanda N.
Publicado 2022

Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial

por Oaknin, Ana, Friedman, Claire F., Roman, Lynda D., D’Souza, Anishka, Brana, Irene, Bidard, François-Clement, Goldman, Jonathan, Alvarez, Edwin A., Boni, Valentina, ElNaggar, Adam C., Passalacqua, Rodolfo, Do, Khanh T.M., Santin, Alessandro D., Keyvanjah, Kiana, Xu, Feng, Eli, Lisa D., Lalani, Alshad S., Bryce, Richard P., Hyman, David M., Meric-Bernstam, Funda, Solit, David B., Monk, Bradley J.
Publicado 2020